NL301115I2 - Drospirenon in combinatie met estetrol - Google Patents

Drospirenon in combinatie met estetrol

Info

Publication number: NL301115I2
Authority: NL; Netherlands
Prior art keywords: estetrol; drospirenone; combination
Prior art date: 2001-05-23

Application number

NL301115C

Other languages

English (en)

Other versions

NL301115I1 (nl

Original Assignee

Estetra Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-23

Filing date

2021-07-07

Publication date

2021-10-25

2001-05-23 Priority claimed from EP01201945A external-priority patent/EP1293210B1/en

2021-07-07 Application filed by Estetra Srl filed Critical Estetra Srl

2021-07-14 Publication of NL301115I1 publication Critical patent/NL301115I1/nl

2021-10-25 Publication of NL301115I2 publication Critical patent/NL301115I2/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NL301115C 2001-05-23 2021-07-07 Drospirenon in combinatie met estetrol NL301115I2 (nl)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
EP01201946		2001-05-23
EP01201947		2001-05-23
EP01201945A EP1293210B1 (en)	2001-05-23	2001-05-23	Means and method for hormonal contraception
EP01204377		2001-11-15
EP02075695		2002-02-21
EP02738961A EP1390042B1 (en)	2001-05-23	2002-05-23	Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
PCT/NL2002/000331 WO2002094279A1 (en)	2001-05-23	2002-05-23	Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception

Publications (2)

Publication Number	Publication Date
NL301115I1 NL301115I1 (nl)	2021-07-14
NL301115I2 true NL301115I2 (nl)	2021-10-25

Family

ID=27513107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL301115C NL301115I2 (nl)	2001-05-23	2021-07-07	Drospirenon in combinatie met estetrol

Country Status (12)

Country	Link
US (1)	US7732430B2 (nl)
EP (1)	EP1390042B1 (nl)
CA (1)	CA2448278C (nl)
CY (2)	CY1108093T1 (nl)
DE (1)	DE60223795T2 (nl)
DK (1)	DK1390042T3 (nl)
ES (1)	ES2296943T3 (nl)
FR (1)	FR21C1033I2 (nl)
LU (1)	LUC00213I2 (nl)
NL (1)	NL301115I2 (nl)
PT (1)	PT1390042E (nl)
WO (1)	WO2002094279A1 (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60318092T2 (de)	2002-10-23	2008-11-27	Pantarhei Bioscience B.V.	Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
DE60332754D1 (de)	2002-11-08	2010-07-08	Pantarhei Bioscience Bv	Synthese von oestetrol aus von oestron abgeleiteten steroiden
SI2714712T1 (sl)	2011-06-01	2016-11-30	Estetra S.P.R.L.	Postopek za proizvodnjo intermediatov estetrola
CN103703014A (zh)	2011-06-01	2014-04-02	埃斯特拉公司	用于产生雌四醇中间体的方法
CA2842175C (en)	2011-07-19	2019-10-15	Herman Jan Tijmen Coelingh Bennink	Tablet containing dehydroepiandrosterone (dhea)
EP2383279A1 (en)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Process for the preparation of estetrol
US9579329B2 (en) *	2011-08-11	2017-02-28	Estetra S.P.R.L.	Use of estetrol as emergency contraceptive
WO2013034780A2 (en)	2012-12-20	2013-03-14	Crystal Pharma, S.A.U.	Process for the preparation of estetrol and related compounds
WO2015040051A1 (en)	2013-09-18	2015-03-26	Crystal Pharma, S.A.U.	Process for the preparation of estetrol
NO3079671T3 (nl) *	2013-12-12	2018-03-24
HUE054551T2 (hu)	2015-06-18	2021-09-28	Estetra Sprl	Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
MA44205B1 (fr)	2015-06-18	2021-04-30	Estetra Sprl	Comprimé orodispersible comprenant estetrol
EP3310333B1 (en)	2015-06-18	2020-04-29	Estetra SPRL	Orodispersible dosage unit containing an estetrol component
SMT201800232T1 (it)	2015-06-18	2018-07-17	Mithra Pharmaceuticals S A	Unita' di dosaggio orodispersibile contenente un componente di estetrolo
KR102712911B1 (ko)	2016-08-05	2024-10-04	에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼	월경통 및 생리통의 관리방법
EP4140489A1 (en) *	2018-02-07	2023-03-01	Estetra SRL	Contraceptive composition with reduced cardiovascular effects
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
HU231240B1 (hu)	2019-09-03	2022-04-28	Richter Gedeon Nyrt.	Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
US20250152604A1 (en)	2022-02-10	2025-05-15	Estetra Srl	Contraceptive methods with scheduled bleeding effects
US12233074B2 (en)	2022-02-10	2025-02-25	Estetra Srl	Contraceptive methods with improved pearl index
HUP2400151A1 (hu)	2024-02-28	2025-09-28	Richter Gedeon Nyrt	Ösztetrol-monohidrát kristályosítási eljárás

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3440320A (en)	1964-06-18	1969-04-22	Mortimer D Sackler	Chelated suppository and method of using same
US3797494A (en)	1969-04-01	1974-03-19	Alza Corp	Bandage for the administration of drug by controlled metering through microporous materials
DE2336433A1 (de)	1973-07-13	1975-04-03	Schering Ag	1.3-oxygenierte 8 alpha-oestratriene
DE2336434A1 (de)	1973-07-13	1975-04-17	Schering Ag	1.3-oxygenierte 8 alpha-oestratriene
DE2426779A1 (de)	1974-05-31	1975-12-18	Schering Ag	1.3-oxygenierte 8 alpha-oestratriene
US4722941A (en)	1978-06-07	1988-02-02	Kali-Chemie Pharma Gmbh	Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
US4460372A (en)	1981-02-17	1984-07-17	Alza Corporation	Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4573996A (en)	1984-01-03	1986-03-04	Jonergin, Inc.	Device for the administration of an active agent to the skin or mucosa
US4624665A (en)	1984-10-01	1986-11-25	Biotek, Inc.	Method of transdermal drug delivery
US4937238A (en)	1986-03-04	1990-06-26	The Board Of Regents Of The University Of Nebraska	Prevention of mammary carcinoma
US4762717A (en) *	1986-03-21	1988-08-09	The General Hospital Corporation	Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5223261A (en)	1988-02-26	1993-06-29	Riker Laboratories, Inc.	Transdermal estradiol delivery system
US5043331A (en)	1989-06-15	1991-08-27	Orion-Yhtyma Oy	Treatment of postmenopausal disorders
US5130137A (en)	1989-08-09	1992-07-14	The General Hospital Corporation	Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders
JPH04235171A (ja)	1990-07-26	1992-08-24	Sumitomo Chem Co Ltd	スルホヒドロキサム酸誘導体、その製造法およびそれを有効成分とする除草剤
US5063507A (en)	1990-09-14	1991-11-05	Plains Cotton Cooperative Association	Goods database employing electronic title or documentary-type title
US5340586A (en)	1991-04-12	1994-08-23	University Of Southern California	Methods and formulations for use in treating oophorectomized women
US5340585A (en)	1991-04-12	1994-08-23	University Of Southern California	Method and formulations for use in treating benign gynecological disorders
US5211952A (en) *	1991-04-12	1993-05-18	University Of Southern California	Contraceptive methods and formulations for use therein
US5468736A (en)	1993-02-25	1995-11-21	The Medical College Of Hampton Road	Hormone replacement therapy
US5895783A (en)	1993-07-16	1999-04-20	Schering Aktiengesellschaft	Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
NL9301562A (nl)	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
DE4344405C2 (de)	1993-12-24	1995-12-07	Marika Dr Med Ehrlich	Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
WO1996003929A1 (en)	1994-08-04	1996-02-15	Biex, Inc.	Method for prediction of premature delivery using estetrol (e4) as an indicator
DE4429374C1 (de) *	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
EP0994718B1 (en)	1997-06-20	2005-08-17	Akzo Nobel N.V.	Gonadotropin releasing hormone antagonist
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6214815B1 (en) *	1998-12-23	2001-04-10	Ortho-Mcneil Pharmaceuticals, Inc.	Triphasic oral contraceptive
DE19917930A1 (de)	1999-04-15	2000-10-19	Schering Ag	Ent-Steroide als selektiv wirksame Estrogene
JP2003527310A (ja)	1999-04-16	2003-09-16	イエナフアルムゲーエムベーハーウントツェーオー．カーゲー	エストロゲンを局部的に皮内投与するための医薬品組成物または化粧品組成物
WO2000073416A1 (en)	1999-05-28	2000-12-07	University Of Cincinnati	Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
WO2001030356A1 (fr)	1999-10-25	2001-05-03	Laboratoire Theramex	Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
AU5984701A (en)	2000-05-12	2001-11-20	Univ Oregon Health & Science	Method of treating immune pathologies with low dose estrogen
US6936599B2 (en)	2001-04-25	2005-08-30	The Regents Of The University Of California	Estriol therapy for multiple sclerosis and other autoimmune diseases
EP1260225A1 (en)	2001-05-18	2002-11-27	Pantarhei Bioscience B.V.	A pharmaceutical composition for use in hormone replacement therapy
ATE347365T1 (de) *	2001-11-15	2006-12-15	Pantarhei Bioscience Bv	Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie

2002
- 2002-05-23 EP EP02738961A patent/EP1390042B1/en not_active Expired - Lifetime
- 2002-05-23 US US10/478,365 patent/US7732430B2/en not_active Expired - Lifetime
- 2002-05-23 PT PT02738961T patent/PT1390042E/pt unknown
- 2002-05-23 CA CA2448278A patent/CA2448278C/en not_active Expired - Lifetime
- 2002-05-23 DK DK02738961T patent/DK1390042T3/da active
- 2002-05-23 DE DE60223795T patent/DE60223795T2/de not_active Expired - Lifetime
- 2002-05-23 WO PCT/NL2002/000331 patent/WO2002094279A1/en not_active Ceased
- 2002-05-23 ES ES02738961T patent/ES2296943T3/es not_active Expired - Lifetime
2008
- 2008-02-04 CY CY20081100136T patent/CY1108093T1/el unknown
2021
- 2021-07-07 NL NL301115C patent/NL301115I2/nl unknown
- 2021-07-08 LU LUC00213 patent/LUC00213I2/en unknown
- 2021-07-26 CY CY2021020C patent/CY2021020I1/el unknown
- 2021-07-27 FR FR21C1033C patent/FR21C1033I2/fr active Active

Also Published As

Publication number	Publication date
DK1390042T3 (da)	2008-03-31
PT1390042E (pt)	2008-03-10
LUC00213I1 (nl)	2021-07-08
EP1390042B1 (en)	2007-11-28
CA2448278A1 (en)	2002-11-28
CY2021020I2 (el)	2021-12-31
EP1390042A1 (en)	2004-02-25
LUC00213I2 (nl)	2021-10-29
CY2021020I1 (el)	2021-12-31
ES2296943T3 (es)	2008-05-01
CY1108093T1 (el)	2014-02-12
US20040198710A1 (en)	2004-10-07
DE60223795T2 (de)	2008-11-27
FR21C1033I2 (fr)	2022-04-22
DE60223795D1 (de)	2008-01-10
FR21C1033I1 (fr)	2021-10-15
CA2448278C (en)	2010-06-08
NL301115I1 (nl)	2021-07-14
WO2002094279A1 (en)	2002-11-28
US7732430B2 (en)	2010-06-08

Publication	Publication Date	Title
NL301115I2 (nl)	2021-10-25	Drospirenon in combinatie met estetrol
DE50106237D1 (de)	2005-06-23	Querträger in Hybridbauweise
DE60135144D1 (de)	2008-09-11	Verbinder
DE60143422D1 (de)	2010-12-23	Verbinder
DE60026949D1 (de)	2006-05-18	Verbinder
DE60102506D1 (de)	2004-05-06	Verbinder
DE10196148T1 (de)	2003-04-30	Zusammengesetztes Bauelement
DE10196135T1 (de)	2003-03-27	Port-Paket-Warteschlangenbildung
FI20000086L (fi)	2001-07-18	Järjestely ohjainsauvan yhteydessä
FI20010557A0 (fi)	2001-03-19	Menetelmä vaihtosuuntaajan yhteydessä
DE60106146D1 (de)	2004-11-11	Verbinder
DE60112673D1 (de)	2005-09-22	Verbinder
DE60107134D1 (de)	2004-12-23	Verbinder
DE60100973D1 (de)	2003-11-20	Verbinder
DE50213606D1 (de)	2009-07-30	Zylinder im Falzapparat
FI20001004L (fi)	2001-10-29	Sovitelma taajuusmuuttajassa
FI20010600L (fi)	2002-09-24	Järjestely luukkurakenteessa
ATE305217T1 (de)	2005-10-15	Ortho-phenylphenolat-konzentrate
FR2827943B3 (fr)	2003-08-29	Profile en c
FI20000318L (fi)	2001-08-16	Järjestely toimilaitteen yhteydessä
DE60219418T8 (de)	2008-04-30	Silanylphenole und -naphthole
HU0102164D0 (en)	2001-07-30	Suppository for antiinfective use in the vagina
DE50004927D1 (de)	2004-02-05	Sitzmöbel
FI20000286A0 (fi)	2000-02-10	Jonotusjärjestelmä
PT1427748E (pt)	2008-08-27	17alfa-hidroxi-14beta-esteróides com efeito hormonal